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Background: In the treatment of vertebral compression fractures, vertebral body stenting with an expandable scaffold
inserted before application of the bone cement was developed to impede secondary loss of vertebral height encoun-
tered in patients treated with balloon kyphoplasty. The purpose of this study was to clarify whether there are relevant
differences between balloon kyphoplasty and vertebral body stenting with regard to perioperative and postoperative
findings.
Methods: In a two-armed randomized controlled trial, patients with a total of 100 fresh osteoporotic vertebral com-
pression fractures were treated with either balloon kyphoplasty or vertebral body stenting. The primary outcome was the
post-interventional change in the kyphotic angle on radiographs. The secondary outcomes were the maximum pressure of
the balloon tamp during inflation, radiation exposure time, perioperative complications, and cement leakage.
Results: The mean reduction (and standard deviation) of kyphosis (the kyphotic correction angle) was 4.5 ± 3.6 after
balloon kyphoplasty and 4.7 ± 4.2 after vertebral body stenting (p = 0.972). The mean pressures were 24 ± 5 bar
(348 ± 72 pounds per square inch [psi]) during vertebral body stenting and 16 ± 6 bar (233 ± 81 psi) during balloon
kyphoplasty (p = 0.014). There were no significant differences in radiation exposure time.
None of the patients underwent revision surgery, and postoperative neurologic sequelae were not observed.
Cement leakage occurred at twenty-five of the 100 vertebral levels without significant differences between
the two intervention arms (p = 0.230). Intraoperative material-related complications were observed at one of the
fifty vertebral levels in the balloon kyphoplasty group and at nine of the fifty levels in the vertebral body stenting
group.
Conclusions: No beneficial effect of vertebral body stenting over balloon kyphoplasty was found among patients with
painful osteoporotic vertebral fractures with regard to kyphotic correction, cement leakage, radiation exposure time, or
neurologic sequelae. Vertebral body stenting was associated with significantly higher pressures during balloon inflation
and more material-related complications.
Level of Evidence: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.
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A
bout 1.4 million patients are affected by clinical vertebral
compression fractures worldwide every year1. With de-
mographic shifts in age2 and sex3, the number of these
fractures will be increasing4. Thus, vertebral compression fractures
represent a major health-care problem of increasing impact5.
Although most of these fractures are asymptomatic, the
resulting loss of vertebral height leads to spinal sagittal im-
balance and sequential vertebral compression fractures in os-
teoporotic patients. Progressive spinal deformity may cause
respiratory and abdominal restrictions. The mortality rate after
the diagnosis of a vertebral compression fracture is approxi-
mately twice as high as that for controls6. Vertebroplasty was
introduced as an alternative to bed rest and mobilization along
with analgesic therapy in 19977. However, recent publications
cast doubt on the effect of classic vertebroplasty, at least on
older fractures, as the inclusion criterion in some early studies
was ‘‘pain less than twelve months.’’8,9 Thus, vertebroplasty was
refined by the use of inflatable balloon tamps (percutaneous
balloon kyphoplasty)10-12. Using a balloon resulted in greater
height restoration13 and less cement leakage as compared with
these parameters following vertebroplasty14.
In theory, deflation of the balloon can be followed by
secondary loss of the initial reduction with a decrease in vertebral
height15. This concern led to the development of an expandable
scaffold that is inserted before the cement to impede secondary
loss of vertebral height (vertebral body stenting)16-18. To our
knowledge, vertebral body stenting has not been evaluated
in vivo; it has only been tested against balloon kyphoplasty in
cadaver specimens17. The advantage of vertebral body stenting
remains theoretical, and the optimal treatment of this patient
population is still debated. The purpose of this prospective
randomized trial was to clarify whether there are differences
between balloon kyphoplasty and vertebral body stenting with
regard to relevant perioperative and postoperative findings.
Materials and Methods
This study was a prospective randomized trial conducted at a single traumacenter of maximum care (Level I) in Switzerland. The study was approved by
our institutional review board (Kantonale Ethikkommission Zu¨rich, Ref. No. 2009-
0117-4), and written informed consent was received from all enrolled patients.
Patients
Patients with one or more osteoporotic vertebral compression fractures of the
thoracic, thoracolumbar, or lumbar spine were eligible (Fig. 1). Osteoporotic
fractures were defined as fractures that occurred spontaneously or as a result of
minimal trauma from day-to-day activities
19
. Fractures were classified according
to the AO classification
20
on preoperative radiographs and computed tomography
Fig. 1
Algorithm for patients included in the study. VBS = vertebral body stenting and BKP = balloon kyphoplasty.
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(CT) scans as described previously
21
, and patients with A1.1, A1.2, A1.3, and A3.1
fractures types were included. Additional inclusion criteria were fresh fractures as
demonstrated on magnetic resonance imaging (MRI) with use of transverse short
tau inverted recovery (STIR) sequences as described previously
22,23
and patients
with marked pain. Exclusion criteria were pregnancy, high-energy trauma, poly-
trauma, previous major spine surgery within one year prior to admission, bone
metastasis, and additional posterior spinal instrumentation. Diagnostic evaluation
included physical examination, preoperative and postoperative anteroposterior
and lateral radiographs, CT (Somatom Definition; Siemens, Munich, Germany;
128-slice dual-source CT; 120 kV, 210 mA), and MRI (Siemens Symphony,
Espree, or Avanto; Siemens Medical Solutions, Erlangen, Germany) including
STIR sequences to determine the age of fractures.
Randomization
Randomization was performed blockwise for five blocks of twenty patients (ten
in arm A and ten in arm B) with use of a web-based computerized algorithm
(www.randomizer.org). The randomization items were not the 100 patients but
the 100 vertebral levels. If more than one level was affected in a single patient, all
fractured vertebrae (levels) were allocated to the same intervention (A). The given
randomization scheme was then completed for the subsequent patient(s) by
balancing leaped interventions B. This was done to avoid different interventions
in the same patient. We used blocks of only ten per arm to be able to use collected
data in case the study was aborted as a result of unexpected complications.
Interventions
All interventions were conducted in the presence and under the supervision of
one of us (C.M.L.W.). Both balloon kyphoplasty and vertebral body stenting
were established procedures at our institution. The procedures were performed
through a percutaneous transpedicular approach with use of Jamshidi needles
and working cannulas as described previously
10,12,18
. After a canal was drilled
into the vertebral body, either a balloon kyphoplasty (KyphX-Systems; Kyphon,
Medtronic, Minneapolis, Minnesota) or a vertebral body stenting (Synthes,
Oberdorf, Switzerland) system was used according to the described randomi-
zation scheme (Fig. 2). Either two balloons (for balloon kyphoplasty) or two
stents (for vertebral body stenting) were placed below the collapsed vertebral
end plate as seen on a fluoroscopic lateral view. The balloon tamps were inflated
slowly and under fluoroscopic and continuous manometric control. A maximum
pressure of 28 bar (400 pounds per square inch [psi]) was allowed according
to both systems’ manufacturer manual. If the stent did not open under 28 bar
(400 psi) during the vertebral body stenting, the pressure was carefully increased
to a maximum of 34 bar (500 psi). Inflation was stopped when either appropriate
reduction or complete balloon expansion within the vertebral body was achieved
or a complication occurred. (i.e., rupture of the balloon). For balloon kypho-
plasty, polymethylmethacrylate cement (KyphX HV-R; Kyphon, Medtronic) was
prepared and viscosity was considered to be optimal when at least a 7-cm ver-
micular cement extrusion could be pressed out of the syringe and stay attached.
For vertebral body stenting, the viscosity of the cement (Vertecem V1 Cement
Kit, VBS; Synthes) was determined with use of the manufacturer’s viscometer
(Viscosafe Viscometer; Synthes). The balloons were removed, and the vertebral
body was filled with cement with bone-filler cannulas and stylets for balloon
kyphoplasty (KyphX Express Bone Filler Device; Kyphon, Medtronic) and sy-
ringes for vertebral body stenting (Vertecem V1 Syringe Kit, VBS; Synthes).
Filling was performed under repetitive fluoroscopic control in two projections
until the cement reached the posterior border or leakage was seen.
Fig. 2
Balloon kyphoplasty (A and B) and vertebral body stenting (C and D) during (A and C) and after (B and D) intervention.
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Measurements and Complications
The primary outcome was the post-interventional change in the kyphotic angle.
Vertebral kyphosis was measured by determining the wedge angle
24
on pre-
operative and postoperative radiographs of every patient with use of a Picture
Archiving and Communication System (PACS)-implemented goniometer.
Intraoperatively, the maximum pressures of the balloon tamps during inflation
and the total radiation exposure time were recorded. A CTscan was added when
a patient had suspected cement outside the vertebral body as seen on the
postoperative radiograph or had intraoperative complications. Intraoperative
cement leaking and material-related complications or failure were documented
on a case report form. All events were cumulated for each level. Only one
complication was recorded if it occurred bilaterally in one vertebra, and two
complications were recorded if they occurred at two levels in the same patient.
Material-related complications outside the patient were not documented. Cement
leakage was defined as ‘‘minor’’ (paravertebral) or ‘‘major’’ (into the venous plexus,
into the spinal canal, behind the anterior longitudinal ligament, or into the in-
tervertebral disc space).
Postoperatively, a full physical examination with a focus on neurologic
sequelae was done.
Statistical Analysis
Sample-size calculation was performed with use of PS: Power and Sample Size
Calculations 3.0 (alpha error: 0.05)
25
. The final sample size of 100 vertebral
levels (group ratio, 1:1; power, 0.95) was based on a proposed difference in the
change in the kyphotic angle of 2.2 ± 3.0 between balloon kyphoplasty and
vertebral body stenting as shown in vitro by Rotter et al.
17
.
Data are expressed as the mean and standard deviation. The primary
analysis includes all vertebral levels that were randomized. Patient-based
comparisons were made between treatment arms with use of Mann-Whitney U
tests (continuous data) or chi-square tests (categorical variables).
To account for clustering of vertebral levels within patients, logistic
regression analysis with the treatment group as a dependent variable and a
robust sandwich estimator for standard errors allowing for intragroup corre-
lation (Stata command logit with option vce [cluster patient]) was used. Stata
11.2 (StataCorp, College Station, Texas) was used for these analyses. All re-
ported p values are two-sided with a level of significance of 0.05. Statistical
analyses were performed by an institutional statistician.
Source of Funding
There was no external funding source for this investigation.
Results
Patients
Sixty-five patients with a mean age (and standard deviation)of 70 ± 13 years were enrolled. Forty women (mean age,
73 ± 10 years) and twenty-five men (mean age, 63 ± 14 years)
with a total of 100 involved vertebral levels (mean, 1.5 levels/
patient; interquartile range, one to two levels/patient) were
treated. Thirty-two (49%) of the sixty-five patients un-
derwent surgery under general anesthesia and thirty-three
(51%), under local anesthesia. The distribution of fracture
morphology according to the AO classification was sex-
dependent (p = 0.015), with type-A3.1 fractures being more
frequent in women and type-A1.1 fractures being more fre-
quent in men. There were no significant differences between
the intervention arms regarding the patients’ baseline charac-
teristics (see Appendix).
Kyphotic Correction
The mean reduction of the kyphosis (kyphotic correction
angle) was 4.5 ± 3.6 (range, 0.0 to 14.3) after balloon
kyphoplasty and 4.7 ± 4.2 (range, 0.0 to 20.0) after ver-
tebral body stenting. The median reduction of the kyphosis
was 4.1 after balloon kyphoplasty and 3.7 after vertebral
body stenting (Fig. 3). These differences were not significant
(Table I).
Pressure and Radiation Exposure Time
The mean pressures were 26 bar (371 psi) in men and 22 bar
(324 psi) in women during vertebral body stenting and 18 bar
(255 psi) and 15 bar (217 psi), respectively, during balloon
kyphoplasty (see Appendix). There was a significant difference
TABLE I Kyphotic Correction, Balloon Pressure, and Radiation Time
Balloon Kyphoplasty* Vertebral Body Stenting* P Value
Kyphotic correction angle () 4.5 ± 3.6 4.7 ± 4.2 0.972
Balloon tamp pressure (psi) 233 ± 81 348 ± 72 0.014†
Radiation time (s) 96 ± 66 116 ± 42 0.462
*Data are expressed as the mean and standard deviation. †Significant at a level of p < 0.05.
Fig. 3
Kyphotic correction. VBS = vertebral body stenting and BKP = balloon
kyphoplasty. The bottom and top of the boxes indicate the first and third
quartiles, the bars indicate the range, the horizontal bars within the boxes
indicate the median, and the circles indicate outliers.
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between the two intervention arms (p = 0.014) (Table I).
Vertebral body stenting was associated with noticeably higher
pressures during balloon inflation (range, 12 to 34 bar [180 to
500 psi]) compared with balloon kyphoplasty (range, 5 to 28
bar [67 to 400 psi]).
There were no significant differences in radiation expo-
sure time between the two intervention arms.
Complications
None of the patients underwent revision surgery as a result of
complications of the primary intervention. There were no
postoperative neurologic sequelae. Cement leakage occurred at
25% of the 100 levels without significant differences between
the two intervention arms (p = 0.230; Table II and Fig. 4). In
total, nine cases of major cement leakage were observed: six
into the paravertebral veins (three in the vertebral body
stenting group and three in the balloon kyphoplasty group),
one behind the anterior longitudinal ligament (vertebral body
stenting), one into the cranial intervertebral disc space (balloon
kyphoplasty), and one into the spinal canal (vertebral body
stenting).
Intraoperative material-related complications occurred
at ten of the 100 levels. Of the fifty balloon kyphoplasties, one
(2%) was associated with a balloon rupture. In contrast, nine
(18%) of the fifty vertebral body stenting procedures were as-
sociated with a material-related complication, including failure
of the working cannulas, incomplete or no opening of the stent,
and balloon rupture (Table II).
While the total number of complications was significantly
higher in the vertebral body stenting group (p = 0.013), there
was no significant difference between the two intervention arms
after elimination of the effect of material failure (i.e., when only
cement leakage and neurologic sequelae were considered).
An analysis of the influence of single and multiple-level
procedures (see Appendix) on the outcome showed no significant
effect on kyphotic reduction (p = 0.411). However, single-level
procedures were associated with significantly more instances of
cement leakage than multilevel procedures (p = 0.001).
In addition, the anatomical fracture level (thoracic, thora-
columbar, or lumbar) had no influence on the occurrence of ce-
ment complications (p = 0.634).
Several material-related complications occurred outside
the patient. These were mainly breakage of the trocar’s plastic
tip, impeding introduction of the system. Since these material
complications did not affect the primary outcome, they were
not documented according to the study protocol.
TABLE II Complications
Balloon Kyphoplasty* Vertebral Body Stenting* P Value Total*
No. of levels 50 50 100
Cement leakage 0.230
None 40 (80%) 35 (70%) 75 (75%)
Minor 6 (12%) 10 (20%) 16 (16%)
Major 4 (8%) 5 (10%) 9 (9%)
Material-related complications 0.043†
Cannula 0 (0%) 5 (10%) 5 (5%)
Balloon 1 (2%) 1 (2%) 2 (2%)
Stent — 3 (6%) 3 (3%)
Neurologic sequelae 0 0 — 0
Total complications 11 (22%) 24 (48%) 0.013† 35 (35%)
*Data are expressed as the number with the percentage in parentheses. †Significant at a level of p < 0.05.
Fig. 4
Cement extrusion (arrows), including paravertebral extrusion (A), extrusion
into the cranial intervertebral disc space (B), and extrusion behind the
anterior longitudinal ligament (C).
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Costs
The material costs (in Switzerland in 2010) for one vertebral
level were approximately $3750 (U.S. dollars) for vertebral
body stenting and $5300 for balloon kyphoplasty. When two or
three levels were treated in the same patient, these costs were
$6950 (two levels) and $10,400 (three levels) for vertebral body
stenting and $5700 and $6300 for balloon kyphoplasty (Fig. 5).
For both systems, one balloon was used several times in the
same patient (unless there was balloon breakage) even if more
than one level was treated.
Discussion
This clinical randomized trial showed no beneficial effect ofvertebral body stenting over balloon kyphoplasty with
regard to the amount of kyphosis correction, radiation expo-
sure time, or cement leakage among patients with painful os-
teoporotic vertebral fractures. Vertebral body stenting was
associated with significantly higher pressures during balloon
inflation and more material-related complications.
Complications
Cement leakage was observed at 20% of the vertebral levels
treated with balloon kyphoplasty and 30% of those treated with
vertebral body stenting; this difference was not significant. Re-
ported leakage rates have ranged from 8.6% to 27.8%11,12,14,26,27 for
balloon kyphoplasty. In most of these studies, the investigators
did not use CT to exclude or verify suspected cement extrusion,
which may explain the higher leakage detection rate in our
population. The only available study related to leakage following
vertebral body stenting18 of which we are aware revealed a ce-
ment leakage rate of 10%. That study, however, included trau-
matic fractures and the included osteoporotic fractures were all
classified as type A1.118. In addition, Klezl et al.18 did not use
Vertecem V1 cement as suggested by the manufacturer of the
vertebral body stenting system; instead, they used the more
viscous KyphX HV-R. This is an off-label use that raises the
question of whether the viscosity of Vertecem V1 itself may be
the cause of cement leakage.
It is important to recognize that cement leakage is pri-
marily a radiographic finding that is not always followed by
clinical symptoms. Although sequential fractures have been de-
scribed after cement leakage into the intervertebral disc space28,
this was not observed in the one patient in our study who had
cement leakage into the intervertebral disc space. Nonetheless,
we believe that balloon kyphoplasty and vertebral body stenting
should be reserved for centers that are able to handle possible
complications such as spinal cord compression.
Vertebral body stenting was associated with higher pres-
sures during balloon inflation. In two cases, the vertebral body
stents did not open at all. We tried to get them to expand in-
traoperatively by exceeding the opening pressures suggested by
the manufacturer. Unfortunately, this led to balloon rupture
rather than stent expansion.
Kyphotic Correction
Balloon kyphoplasty is known to result in a kyphotic correction
of 4 to 726,28, and the only clinical study of vertebral body
stenting of which we are aware demonstrated a kyphotic cor-
rection of 4.5 in osteoporotic patients18. The kyphotic cor-
rection observed in our two intervention arms is consistent
with previously published clinical data.
Vertebral body stenting did not achieve the initial goals of
avoiding secondary loss of vertebral height and less cement
leakage in our study. One important reason for this was that the
stents frequently failed to open properly (see Appendix). This
led to insufficient expansion of the balloon tamps with un-
satisfactory fracture reduction and was followed by increased
pressures during inflation and in some cases by balloon rup-
ture. It was stressed previously that precise positioning of the
two stents is crucial in vertebral body stenting18.
Both tested procedures had been established for at least
one year at our hospital before the present trial was begun. It
therefore is unlikely that the results were due to a learning
curve29. However, precise positioning of the stents can be dif-
ficult in some fractures, and the capacity to tolerate variance is
obviously smaller with vertebral body stenting than it is with
balloon kyphoplasty. Once the stent is inserted or even ex-
panded, repositioning or removal is very difficult. Salvage
procedures such as eggshell techniques are not possible.
Costs
We did not evaluate the individual costs per patient; instead we
examined the standard general material costs per level. Consid-
ering the 1.5 levels per patient treated in the present study, we
found no remarkable difference in costs between the two sys-
tems. One has to take into account the many material-related
Fig. 5
Material costs according to the manufacturers for one, two, and three
levels. BKP = balloon kyphoplasty, VBS = vertebral body stenting, and
USD = U.S. dollars.
582
TH E J O U R N A L O F B O N E & JO I N T SU R G E RY d J B J S . O R G
VO LU M E 95-A d NU M B E R 7 d AP R I L 3, 2013
VERTEBRAL BODY STENTING VERSUS KYPHOPLASTY FOR THE TREATMENT
OF OSTEOPOROTIC VERTEBRAL COMPRESSION FRACTURES
complications that led to the use of multiple sets in the same
patient as this increased the costs per patient. In addition, it has to
be considered that, although no substantial differences in costs
were found, vertebral body stenting was compared with a balloon
kyphoplasty system (KyphX-Systems) that is rather expensive30.
A limitation of this trial is that it was not possible to blind
both treatment and measurements because of the obvious char-
acteristics of the implants. However, as not one eligible patient was
excluded and crossovers were not possible, selection bias was
avoided and intention-to-treat analysis was guaranteed.
The present study focused on perioperative and post-
operative events. Therefore, no statements regarding potential
effects on the clinical outcome can be made. However, we could
not confirm that adding a vertebral stent avoided secondary
loss of vertebral height, and without achieving this goal a
clinical effect is at least questionable.
Patients with fresh osteoporotic fractures as demon-
strated with MRI STIR sequences accompanied by severe pain
were included in this study. Because of the population’s char-
acteristics (age and multiple/repetitive falls), it is often difficult
or impossible to determine the true age of osteoporotic frac-
tures on the basis of the patient’s history; thus, MRI is useful to
exclude advanced consolidation. In contrast, one may assume
that studies of therapies for vertebral compression fractures
without prior MRI sometimes include old fractures31.
Even with use of MRI, inclusion of old fractures was
possible. If vertebral body stenting was applied to fractures
beyond an early stage, that might explain higher pressures re-
quired for balloon opening, which would explain higher rates
of material-related complications and cement leakage. This
would lead to the recommendation of using vertebral body
stenting only in the immediate posttraumatic period or within
a few days after the onset of symptoms. However, to our
knowledge, this study is the first interventional vertebral
compression fracture trial in which MRI was used for every
patient. Trials using a more precise determination of fracture
age have not yet been published.
In conclusion, we found no beneficial effect of vertebral
body stenting over balloon kyphoplasty with regard to kyphotic
correction, cement leakage, radiation exposure time, or neu-
rologic sequelae among patients with painful osteoporotic
vertebral fractures. Vertebral body stenting was associated with
significantly higher pressures during balloon inflation and re-
markably more material-related complications.
Appendix
Tables showing patients’ baseline characteristics and
number of levels treated per patient as well as figures
showing maximum intraoperative balloon pressure and failure
of stent opening are available with the online version of this
article as a data supplement at jbjs.org. n
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